<DOC>
	<DOCNO>NCT00802464</DOCNO>
	<brief_summary>The goal randomize observer-blind trial refine formulation vaccine contain GSK1437173A old adult compare cellular humoral immune response safety profile different formulation .</brief_summary>
	<brief_title>Immunogenicity Safety Study GSK Biologicals ' Herpes Zoster Vaccine With Various Formulations Adults &gt; = 50 Years</brief_title>
	<detailed_description />
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A male female 50 year age time first vaccination ; Written inform consent obtain subject ; Subjects investigator believe comply requirement protocol enrol study ; If subject female , must nonchildbearing potential , childbearing potential , must practice adequate contraception 30 day prior vaccination , negative pregnancy test continue precaution 2 month completion vaccination series . Use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day precede first dose study vaccine , plan use study period ; Chronic administration ( define 14 consecutive day ) immunosuppressant immunemodifying drug within three month prior first vaccine dose . Planned administration/ administration vaccine foreseen study protocol within one month first study vaccination schedule within 30 day study vaccination ; Previous vaccination HZ ; Previous vaccination varicella ; History HZ ; History allergic disease reaction likely exacerbate component vaccine ; Any confirm suspected immunosuppressive immunodeficient condition result disease immunosuppressive/cytotoxic therapy ; Administration immunoglobulins and/or blood product within 3 month precede first injection study vaccine plan administration study period ; Acute disease time enrolment . Any condition , opinion investigator , might interfere evaluation require study ; History current drug and/or alcohol abuse ; Pregnant lactate female ; Female planning become pregnant planning discontinue contraceptive precaution childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cytokine</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Herpes Zoster ( HZ )</keyword>
	<keyword>Cell mediate immunity ( CMI )</keyword>
	<keyword>Antibody response</keyword>
	<keyword>Varicella Zoster Virus ( VZV )</keyword>
	<keyword>Shingles</keyword>
</DOC>